Medical News

RSS

TeleTracking Technologies, Sodexo announce multi-year renewal of sales partnership

TeleTracking Technologies and Sodexo, Inc. today announced a multi-year renewal of their long-standing sales partnership to bring automated patient flow and transport solutions to hospitals.

4 Jun 2010

Earliest blood flow begins all at once

By capturing movies of both the blood and vasculature of zebrafish embryos, each less than two millimeters long, researchers have been able for the first time to see the very moment that blood begins to flow.

4 Jun 2010

Antiemetic-regimen with fosaprepitant injection provides similar protection against CINV as oral EMEND

Merck announced today results from a new non-inferiority trial of an antiemetic regimen containing fosaprepitant dimeglumine administered as a single intravenous (IV) 150-mg dose in combination with a 5-HT3 antagonist and dexamethasone compared with a three-day regimen of aprepitant with a 5-HT3 antagonist and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving a first cycle of cisplatin-based chemotherapy.

4 Jun 2010

Author shows how to inspire a change in attitude to create new rhythm of life

The importance of living a fulfilling life is a theme that has launched many talk shows, best-selling books and fitness regiments. While navigating all this information may seem daunting, author Herbert Santos Silva makes it simple in his new book, "A Walk in the Garden of Wisdom: Intuitive Reflections" (published by AuthorHouse).

4 Jun 2010

Labopharm comments on the outcome of patent-infringement litigation related to Ultram ER

Labopharm Inc. today commented on the outcome of the appeal by Purdue Pharma Products L.P. and the cross-appeal by Par Pharmaceutical Companies, Inc. of the decision of the United States District Court for the District of Delaware in August 2009 on patent-infringement litigation initiated by Purdue against Par relating to Ultram ER (tramadol hydrochloride extended-release tablets).

4 Jun 2010

Researchers induce memory of safety in brain of rats

Researchers have found a way to pharmacologically induce a memory of safety in the brain of rats, mimicking the effect of training. The finding suggests possibilities for new treatments for individuals suffering from anxiety disorders.

4 Jun 2010

Diagnosis of antiovarian autoantibodies in infertile women help in approaches for assisted reproduction

Studies on the ovarian antigens and its corresponding specific antibodies have showed the relationship between the incidences of antiovarian autoantibodies and the clinical mani-festation of ovarian dysfunction and infertility in women.

4 Jun 2010

Bertucci’s Chef chosen to participate in First Lady Michelle Obama's Chefs Move To Schools program

Northborough, MA-based Bertucci’s Corporation announced today that it’s own Chef Stefano Cordova has been chosen by First Lady Michelle Obama to participate in her “Chefs Move To Schools” program that calls on the nation’s chefs to adopt a school, work with teachers, parents, school nutritionists and administrators to help educate kids about food and nutrition.

4 Jun 2010

Reprints Desk to sponsor and exhibit at two pharmaceutical marketing events

Derycz Scientific, Inc., a company that is pioneering a fresh way of facilitating the flow of information from content publishers to enterprise customers and their constituents, today announced that Reprints Desk, an award-winning provider of information services and content workflow solutions, will sponsor and exhibit at two pharmaceutical marketing events: Digital Pharma West, being held in San Francisco from June 28-30, 2010, and Digital Pharma East, being held in Philadelphia from October 18-20, 2010.

4 Jun 2010

MediQuant announces DataArk for managing legacy healthcare data from older applications

DataArk™ from MediQuant is an active archive that houses legacy clinical, financial, revenue cycle management and other health information system (HIS) data. Today, many hospitals and healthcare organizations are converting to new HIS or Enterprise Resource Planning (ERP) systems.

4 Jun 2010

6th Research Congress of the EAPC reflects research in palliative care

The global interest for research in palliative care is increasing rapidly and The 6th Research Congress of the EAPC reflects this with a record number of abstracts and attendees -- more than 660 abstracts from 39 different countries will be presented to over 1200 international researchers and clinicians.

4 Jun 2010

ASCO 2010 marks first anniversary of "Cancer Patient Statement of Principles"

The International Myeloma Foundation (IMF), the oldest and largest foundation dedicated to improving the life and care of myeloma patients, notes the 2010 Annual Meeting of the American Society for Clinical Oncology (ASCO) marks the first anniversary of the "Cancer Patient Statement of Principles."

4 Jun 2010

Nuon Therapeutics' abstracts on tranilast against gout accepted for presentation at EULAR 2010

Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced that two scientific abstracts on the activity of tranilast against key components of gout - high serum uric acid levels and monosodium urate crystal-induced inflammation - have been accepted for The European League Against Rheumatism (EULAR) 2010 Annual European Congress of Rheumatology, to be held in Rome, Italy, June 16-19, 2010.

4 Jun 2010

Preclinical data of dual TLR7 and TLR8 agonist in cancer published

Idera Pharmaceuticals, Inc. today announced the publication of data from studies of a dual agonist of Toll-like Receptor 7 and TLR8 in preclinical models of cancer. The Company created this first-in-class RNA-based dual agonist of TLR7 and TLR8 through its chemistry-based approach to identifying novel TLR-targeted drug candidates.

4 Jun 2010

Freescale Semiconductor develops portable medical kiosk to run routine health screenings at home

As the population continues to age and medical monitoring becomes more integrated into everyday living, healthcare professionals are constantly striving to find new ways to monitor patients with improved accuracy, speed and end-user convenience. Taking an active part in this initiative, Freescale Semiconductor, partnering with Pounce Consulting, developed a portable, easy-to-use telemonitoring reference design, which allows patients and physicians to run routine health screenings at home or remotely.

4 Jun 2010

Montefiore-Einstein announces Abdominal Organ Transplant Symposium on June 10, 2010

The Montefiore-Einstein Abdominal Organ Transplantation Service will hold an Abdominal Organ Transplant Symposium on Thursday, June 10, 2010 from 7:30 am - 4:30 pm at the Moses Division of Montefiore Medical Center on Gun Hill Road in the Bronx, NY.

4 Jun 2010

Roche's new dual-PCR target HIV-1 viral load test receives FDA approval

Roche Molecular Diagnostics announced today that the Food and Drug Administration (FDA) approved its new dual-PCR target HIV-1 viral load test to quantify the amount of virus in a patient's blood. The COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 Test, v2.0 is the first quantitative viral load test to amplify and detect two separate regions of a target genome and offers a fully automated and reliable solution for physicians to make informed treatment decisions for HIV-1 patients undergoing antiretroviral therapy.

4 Jun 2010

Researchers develop biosensors to monitor concentration of c-di-GMP within single living bacteria cells

Some species of bacteria perform an amazing reproductive feat. When the single-celled organism splits in two, the daughter cell - the swarmer - inherits a propeller to swim freely. The mother cell builds a stalk to cling to surfaces.

4 Jun 2010

First Edition: June 4, 2010

Today's health policy headlines highlight HHS Secretary Sebelius' defense of the Obama administration's Medicare nominee as well as the AMA's push to fix scheduled reductions in Medicare physician payments.

4 Jun 2010

Promising results of ABRAXANE for bladder cancer support efficacy of nab-driven chemotherapy

Abraxis BioScience, Inc. announced today that findings from a phase 1 randomized trial demonstrated that the nanoparticle albumin bound (nab®) driven chemotherapy, nab-paclitaxel (ABRAXANE® for Injectable Suspension; paclitaxel albumin protein-bound particles for injectable suspension) is well-tolerated and active in the second-line treatment of high-grade, non-muscle-invasive bladder cancer that has been refractory to standard intra-bladder infusion (intravesical) therapy.

4 Jun 2010

Medical News

TeleTracking Technologies, Sodexo announce multi-year renewal of sales partnership

Earliest blood flow begins all at once

Antiemetic-regimen with fosaprepitant injection provides similar protection against CINV as oral EMEND

Author shows how to inspire a change in attitude to create new rhythm of life

Labopharm comments on the outcome of patent-infringement litigation related to Ultram ER

Researchers induce memory of safety in brain of rats

Diagnosis of antiovarian autoantibodies in infertile women help in approaches for assisted reproduction

Bertucci’s Chef chosen to participate in First Lady Michelle Obama's Chefs Move To Schools program

Reprints Desk to sponsor and exhibit at two pharmaceutical marketing events

MediQuant announces DataArk for managing legacy healthcare data from older applications

6th Research Congress of the EAPC reflects research in palliative care

ASCO 2010 marks first anniversary of "Cancer Patient Statement of Principles"

Nuon Therapeutics' abstracts on tranilast against gout accepted for presentation at EULAR 2010

Preclinical data of dual TLR7 and TLR8 agonist in cancer published

Freescale Semiconductor develops portable medical kiosk to run routine health screenings at home

Montefiore-Einstein announces Abdominal Organ Transplant Symposium on June 10, 2010

Roche's new dual-PCR target HIV-1 viral load test receives FDA approval

Researchers develop biosensors to monitor concentration of c-di-GMP within single living bacteria cells

First Edition: June 4, 2010

Promising results of ABRAXANE for bladder cancer support efficacy of nab-driven chemotherapy

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News